Fecal Transplants in Kidney Recipients Reduced Resistant Pathogens
In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer times to recurrent infections. Eight of 10 participants who received a least one FMT, and eight of nine participants who received all FMT treatments were multidrug-resistant organism (MDRO) negative by day […]